Hims & Hers Health, Inc. HIMS
29.42
0.14
0.48%
as of 25 Sep
- Market cap
- $6.9B
- P/E
- 0.0×
Follow HIMS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (32.03%) | (2.66%) | 25.23% | 26.21% |
+8 more TTM periods Free account |
|
| (5.16%) | (0.84%) | 8.97% | 9.44% | ||
ROIC |
(11.38%) | (2.86%) | 7.05% | 7.79% | |
Return on Tangible Assets |
(53.48%) | (1.74%) | 19.01% | 20.21% | |
Average Days of Receivables |
53.13 | 23.05 | 5.00 | 0.00 | |
Free Cash Flow per Share |
0.36 | 0.35 | 0.33 | 0.59 | |
Free Cash Flow |
83.03 | 79.71 | 73.96 | 133.90 | |
Capital Expenditures |
(180.42) | (200.56) | (226.04) | (191.18) | |
Piotroski F-Score |
3.00 | 3.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
10.41% | 12.91% | 14.35% | 14.90% | |
Accounts Receivable Turnover |
13.60 | 30.76 | 132.71 | 0.00 | |
Accounts Payable Turnover |
2.69 | 3.22 | 5.24 | 4.03 | |
Inventory Turnover |
7.09 | 8.64 | 8.50 | 7.12 | |
Average Days of Payables |
224.78 | 167.11 | 85.14 | 131.08 | |
Days of Inventory on Hand |
39.36 | 43.06 | 47.61 | 70.02 | |
Tax Rate |
(0.13) | (0.65) | 0.04 | 0.05 | |
Research and Development Expense of Revenue |
7.11% | 7.02% | 6.36% | 5.97% | |
Selling, General and Administrative Expense of Revenue |
53.77% | 52.49% | 50.78% | 51.87% | |
Share Based Compensation of Revenue |
5.96% | 6.21% | 5.76% | 5.66% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.85) | (21.18) | 2.34 | 2.43 | |
Depreciation/Fixed assets |
0.25 | 0.22 | 0.18 | 0.16 | |
Capex/Depreciation |
(1.95) | (2.77) | (3.97) | (4.44) | |
Revenue per Share |
11.12 | 10.38 | 10.44 | 9.77 | |
Operating CF per Share |
1.14 | 1.23 | 1.33 | 1.44 | |
Capex per Share |
(0.78) | (0.88) | (1.00) | (0.84) | |
Capex to Sales |
0.07 | 0.08 | 0.10 | 0.09 | |
Net Profit Margin |
(5.51%) | (0.56%) | 5.47% | 6.05% |
Columns are period end dates